Annual Interest Expense
$2.79 M
+$1.76 M+170.28%
31 December 2023
Summary:
Galectin Therapeutics annual interest expense is currently $2.79 million, with the most recent change of +$1.76 million (+170.28%) on 31 December 2023. During the last 3 years, it has risen by +$2.71 million (+3109.20%). GALT annual interest expense is now at all-time high.GALT Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$1.49 M
+$225.00 K+17.73%
30 September 2024
Summary:
Galectin Therapeutics quarterly interest expense is currently $1.49 million, with the most recent change of +$225.00 thousand (+17.73%) on 30 September 2024. Over the past year, it has increased by +$659.00 thousand (+78.92%). GALT quarterly interest expense is now at all-time high.GALT Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$4.66 M
+$659.00 K+16.46%
30 September 2024
Summary:
Galectin Therapeutics TTM interest expense is currently $4.66 million, with the most recent change of +$659.00 thousand (+16.46%) on 30 September 2024. Over the past year, it has increased by +$2.41 million (+106.92%). GALT TTM interest expense is now at all-time high.GALT TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +170.3% | +78.9% | +106.9% |
| 3 y3 years | +3109.2% | +1246.0% | +1842.5% |
| 5 y5 years | +731.0% | +6690.9% | +3115.2% |
GALT Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +3109.2% | at high | +1246.0% | at high | +1842.5% |
| 5 y | 5 years | at high | +3109.2% | at high | +7014.3% | at high | +5258.6% |
| alltime | all time | at high | at high | at high |
Galectin Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.49 M(+17.7%) | $4.66 M(+16.5%) |
| June 2024 | - | $1.27 M(+20.6%) | $4.00 M(+18.3%) |
| Mar 2024 | - | $1.05 M(+24.2%) | $3.38 M(+21.2%) |
| Dec 2023 | $2.79 M(+170.3%) | $847.00 K(+1.4%) | $2.79 M(+23.9%) |
| Sept 2023 | - | $835.00 K(+28.5%) | $2.25 M(+33.6%) |
| June 2023 | - | $650.00 K(+41.3%) | $1.69 M(+33.3%) |
| Mar 2023 | - | $460.00 K(+49.4%) | $1.27 M(+22.6%) |
| Dec 2022 | $1.03 M(+111.2%) | $308.00 K(+14.5%) | $1.03 M(+3.6%) |
| Sept 2022 | - | $269.00 K(+17.5%) | $997.00 K(+18.8%) |
| June 2022 | - | $229.00 K(+0.9%) | $839.00 K(+20.7%) |
| Mar 2022 | - | $227.00 K(-16.5%) | $695.00 K(+41.8%) |
| Dec 2021 | $489.00 K(+462.1%) | $272.00 K(+145.0%) | $490.00 K(+104.2%) |
| Sept 2021 | - | $111.00 K(+30.6%) | $240.00 K(+58.9%) |
| June 2021 | - | $85.00 K(+286.4%) | $151.00 K(+73.6%) |
| Mar 2021 | - | $22.00 K(0.0%) | $87.00 K(0.0%) |
| Dec 2020 | $87.00 K(0.0%) | $22.00 K(0.0%) | $87.00 K(0.0%) |
| Sept 2020 | - | $22.00 K(+4.8%) | $87.00 K(0.0%) |
| June 2020 | - | $21.00 K(-4.5%) | $87.00 K(0.0%) |
| Mar 2020 | - | $22.00 K(0.0%) | $87.00 K(0.0%) |
| Dec 2019 | $87.00 K(-74.1%) | $22.00 K(0.0%) | $87.00 K(-40.0%) |
| Sept 2019 | - | $22.00 K(+4.8%) | $145.00 K(-31.0%) |
| June 2019 | - | $21.00 K(-4.5%) | $210.00 K(-23.4%) |
| Mar 2019 | - | $22.00 K(-72.5%) | $274.00 K(-18.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $336.00 K(+2700.0%) | $80.00 K(-8.0%) | $336.00 K(+31.3%) |
| Sept 2018 | - | $87.00 K(+2.4%) | $256.00 K(+51.5%) |
| June 2018 | - | $85.00 K(+1.2%) | $169.00 K(+101.2%) |
| Mar 2018 | - | $84.00 K(>+9900.0%) | $84.00 K(>+9900.0%) |
| Dec 2017 | $12.00 K(>+9900.0%) | - | - |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | - | - |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00 | $0.00 |
| Dec 2008 | $0.00 | - | - |
FAQ
- What is Galectin Therapeutics annual interest expense?
- What is the all time high annual interest expense for Galectin Therapeutics?
- What is Galectin Therapeutics annual interest expense year-on-year change?
- What is Galectin Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Galectin Therapeutics?
- What is Galectin Therapeutics quarterly interest expense year-on-year change?
- What is Galectin Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Galectin Therapeutics?
- What is Galectin Therapeutics TTM interest expense year-on-year change?
What is Galectin Therapeutics annual interest expense?
The current annual interest expense of GALT is $2.79 M
What is the all time high annual interest expense for Galectin Therapeutics?
Galectin Therapeutics all-time high annual interest expense is $2.79 M
What is Galectin Therapeutics annual interest expense year-on-year change?
Over the past year, GALT annual interest expense has changed by +$1.76 M (+170.28%)
What is Galectin Therapeutics quarterly interest expense?
The current quarterly interest expense of GALT is $1.49 M
What is the all time high quarterly interest expense for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly interest expense is $1.49 M
What is Galectin Therapeutics quarterly interest expense year-on-year change?
Over the past year, GALT quarterly interest expense has changed by +$659.00 K (+78.92%)
What is Galectin Therapeutics TTM interest expense?
The current TTM interest expense of GALT is $4.66 M
What is the all time high TTM interest expense for Galectin Therapeutics?
Galectin Therapeutics all-time high TTM interest expense is $4.66 M
What is Galectin Therapeutics TTM interest expense year-on-year change?
Over the past year, GALT TTM interest expense has changed by +$2.41 M (+106.92%)